Concourse Financial Group Securities, Inc. Context Therapeutics Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
16 transactions
Others Institutions Holding CNTX
# of Institutions
42Shares Held
76.1MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$16.5 Million1.9% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$8.37 Million1.33% of portfolio
-
Nextech Invest, Ltd. Zurich, V87.42MShares$8.31 Million0.92% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$8.31 Million0.17% of portfolio
-
Nextech Invest Ag7.42MShares$8.31 Million1.37% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $17.9M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...